Product Description.:
Pfizer, JKI 5
tablet , film-coated , white , round round
Debossed
VISIT XELJANZ.COM FOR ALL INFORMATION
What is XELJANZ?
XELJANZ is a prescription medicine called a Janus kinase (JAK) inhibitor. XELJANZ is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well.
It is not known if XELJANZ is safe and effective in people with hepatitis B or C.
XELJANZ is not for people with severe liver problems.
It is not known if XELJANZ is safe and effective in children.
IMPORTANT SAFETY INFORMATION
What is the most important information I should know about XELJANZ?
XELJANZ may cause serious side effects, including:
Serious infections. XELJANZ can lower the ability of your immune system to fight infections. Some people have serious infections while taking XELJANZ, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections. Your healthcare provider should test you for TB before starting XELJANZ, and monitor you closely for signs and symptoms of TB infection during treatment. You should not start taking XELJANZ if you have any kind of infection unless your healthcare provider tells you it is okay.
Before starting XELJANZ, tell your healthcare provider if you:
The first in a new class of treatments.
A powerful RA treatment that fits in the palm of your hand
Hands were made for holding. Arms were made for hugging. Your body was made for better things than the symptoms of rheumatoid arthritis (RA). If you're interested in another way to treat moderate to severe RA, learn more about XELJANZ.
XELJANZ ( pronounced zel-jans ) is the first in a new class of treatments for moderate to severe RA. Called a Janus-associated kinase (JAK) inhibitor, it helps to reduce common RA symptoms such as joint pain, swelling, and stiffness.
XELJANZ works deep inside cells to help disrupt the signaling of cytokines associated with the inflammation of RA. An oral medication available by prescription, XELJANZ is a small pill taken twice a day. In clinical studies, some patients taking XELJANZ experienced a reduction in joint pain and swelling within 2 weeks. For some others, it took 3-6 months. However, every patient is different, so your results may vary.
If you believe your current RA treatment is not doing enough for your moderate to severe RA symptoms, and you have not responded to or tolerated methotrexate, ask your rheumatologist about XELJANZ. Together, you can determine if XELJANZ may be an option for you.
